BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Pre-Clinical
Harvard Apparatus (HART) Regenerative Technology Collaborator Successfully Transplants Regenerated Esophagus Into Rat 4/15/2014  More...
True North Therapeutics Publishes Study In Blood Demonstrating Ex Vivo Efficacy Of A C1s Antibody In Cold Agglutinin Disease Patient Samples 4/14/2014  More...
Intercept Pharmaceuticals (ICPT) Announces Preclinical Data Demonstrating OCA's Potential Role In Preventing Complications Of Cirrhosis 4/11/2014  More...
Albireo’s Lead Compound In Cholestatic Liver Diseases, A4250, Protects Against Bile Acid-Mediated Cholestatic Liver Injury In Mice 4/11/2014  More...
ERYtech Pharma Picks Up A New Candidate For Its Tumor Starvation Pipeline 4/9/2014  More...
Immunomedics, Inc. (IMMU) Reports Preclinical Results On SN-38 Antibody-Drug Conjugates As A Potential Novel Platform For Treating Cancer 4/8/2014  More...
Hemispherx Biopharma (HEB) Announces New Publication Enlarges The Understanding Of Ampligen® Safety Profile Across Diverse Animal Species And Focuses On The Unique TLR-3 Receptor/Ampligen(R) Interaction 4/8/2014  More...
Kadmon Corporation Presents Preclinical Results Demonstrating KD019 Activity In Trastuzumab Resistant HER2+ Breast Cancer 4/8/2014  More...
MacroGenics, Inc. (MGNX) Presents Pre-Clinical Data Demonstrating Potent Activity With Colorectal Cancer Product Candidate MGD007 At The American Association for Cancer Research Annual Meeting 4/7/2014  More...
Domainex Ltd Programme Shows Great Promise For The Treatment Of Inflammatory Diseases, Such As Chronic Obstructive Pulmonary Disease (COPD) 4/7/2014  More...
Threshold Pharmaceuticals, Inc. (THLD) Announces Results Of Two New Preclinical Studies Evaluating Novel Combinations Of TH-302 With Immunotherapy, Antiangiogenic Therapy, And Radiotherapy To Be Presented At American Association for Cancer Research Annual Meeting 2014 4/4/2014  More...
Cempra Pharmaceuticals, Inc.'s Solithromycin Demonstrates Therapeutic Potential Beyond Anti-Bacterial Activity 4/4/2014  More...
Antisense Therapeutics Limited (ANP.AX) Release: ATL1102 For MS - Toxicology Study Main Findings 4/1/2014  More...
Nuvilex Selects Translational Drug Development (TD2) To Advance Treatment For Pancreatic Cancer 4/1/2014  More...
TetraLogic Pharmaceuticals (TLOG) Announces Publication Of Preclinical Characterization Of Birinapant 4/1/2014  More...
Egalet Reports Positive Outcome Of First Phase Of Category 1 Abuse Deterrence Studies For Egalet-001 3/31/2014  More...
Kindred Bio (KIN) Announces Initiation Of Pivotal Clinical Study For SentiKin™ In Dogs 3/31/2014  More...
Pulmokine Awarded $1.5 Million Stage B VITA Contract To Advance Inhaled Kinase Inhibitors For Pulmonary Arterial Hypertension 3/27/2014  More...
Cempra To Present Late-Breaker On Solithromycin Reducing Inflammation In An Animal Model For Cancer Chemotherapy-Induced Lung Injury 3/27/2014  More...
AHCC Research Association Release: HPV Eradicated By AHCC Supplement, Preclinical Study Suggests 3/24/2014  More...
Patrys Limited (PAB.AX) PAT-LM1 Advancing To The Clinic 3/24/2014  More...
Isis Pharmaceuticals, Inc. (ISIS) Announces Antisense Targeting Of HBV Produces Dose-Dependent Reductions In Hepatitis B Virus In An Animal Model Of HBV 3/24/2014  More...
GeoVax Labs Inc. (GOVX.OB) Announces Publication Of Repeat Challenge Preclinical Trial In The Journal Of Virology 3/19/2014  More...
Calithera Biosciences, Inc. Presents Preclinical Data For CB-839 Activity And Glutaminase Inhibition In Solid And Hematologic Tumors 3/18/2014  More...
Novagen, Inc. And CanTx Experimental Drug, Trx-1, Proves Effective In Vivo 3/18/2014  More...
Kymab Announces Publication Of The Kymouse Technology In Nature Biotechnology 3/17/2014  More...
The CMTA Announces Expansion of Preclinical Testing For Hereditary Neuropathy Therapies 3/14/2014  More...
Preclinical Data Presentations At Keystone Symposia Highlight Broad Immunotherapy Potential Of Peregrine Pharmaceuticals, Inc. (PPHM)' PS-Targeting Antibodies 3/14/2014  More...
Preclinical Results For Pluristem Therapeutics (PSTI)'s PLX-PAD Cells In Tendon Injury Presented At American Academy of Orthopaedic Surgeons' Annual Meeting 3/12/2014  More...
Anavex Life Sciences Corp. (AVXL.OB) Encouraged By Scientific Data Confirming Sigma-1 Receptor Agonist Extends Survival in ALS (Lou Gehrig's Disease) 3/10/2014  More...
Heat Biologics Presents Preclinical Data From Comparative Combination Cancer Immunotherapy Research Study At Keystone Symposia On Immune Evolution In Cancer 3/10/2014  More...
Research Report Confirms Opportunity For Anavex Life Sciences Corp. (AVXL.OB) Anti-Cancer And Neuropathic Pain Compounds 2/26/2014  More...
Kindred Bio (KIN) Announces Initiation Of Pivotal Clinical Study For Atokin™ In Dogs 2/20/2014  More...
Preclinical Study Results Of Merrimack Pharmaceuticals Inc. (MACK)'s MM-141 Published In Molecular Cancer Therapeutics 2/18/2014  More...
Mirna Therapeutics, Inc. Announces Scientific Publication That Suggests Enhanced Potency Of Lead Therapeutic Microrna In Combination With FDA Approved Lung Cancer Dru 2/18/2014  More...
New Drug Candidate From Vivolux Starves Cancer Cells – Clinical Study Due To Begin Shortly 2/18/2014  More...
BioLineRx Ltd. Announces Positive Preclinical Results For Novel Treatment For Chronic Myeloid Leukemia 2/12/2014  More...
DATATRAK International, Inc. (DATA) Enters Preclinical Trials Extending Leadership Across All Trial Phases 2/4/2014  More...
Cellectis Grants genOway An Exclusive Sublicense For Its Homologous Recombination Technology In The Field Of Genetically Modified Rodent Models 2/4/2014  More...
GENFIT Corp. (ALGFT): Preclinical Data Support Anti-Cancer Effects Of GFT505 1/29/2014  More...
Alcobra (ADHD) Announces New Biomarker Finding In A Follow-Up Fragile X Animal Study For MG01CI 1/27/2014  More...
Novozymes Biopharma Announces New Data Highlighting Potential For Monthly Drug Dosing 1/27/2014  More...
NovoCure Ltd. Enrolls First Patient In Pilot Clinical Trial Of Novottf™ Therapy Plus Gemcitabine For First-Line Treatment Of Advanced Pancreatic Adenocarcinoma 1/24/2014  More...
Clasado And University of Oxford Demonstrate Effect Of Prebiotics On Brain And Gut In Pre-Clinical Study 1/23/2014  More...
Karyopharm Therapeutics (KPTI) Presents Clinical Data On Selinexor (KPT-330) In Colorectal Cancer From Ongoing Phase 1 Study And Preclinical Data On Novel PAK4 Inhibitors At American Society of Clinical Oncology 2014 Gastrointestinal Cancers Symposium 1/22/2014  More...
Preclinical Study Demonstrates Effect Of Galectin Therapeutics Inhibitor On Serum Biomarker In Fatty Liver Disease With Fibrosis 1/21/2014  More...
Innovimmune Biotherapeutics, Inc.'s Preclinical Data On Highly Selective ROR Gamma Inhibitor Prevents Multiple Sclerosis In Mice 1/15/2014  More...
MediciNova, Inc. Announces Positive Results In NASH Mouse Model With MN-001 And Prepares To Initiate Phase 2 Trial In The U.S. 1/14/2014  More...
Merrimack Pharmaceuticals Inc. (MACK) To Present Preclinical Data At The American Society of Clinical Oncology 2014 Gastrointestinal Cancers Symposium 1/13/2014  More...
Cubist Pharmaceuticals, Inc. (CBST) Submits Clinical Trial Application To Initiate First-In-Human Study Of CB-618—A Beta-Lactamase Inhibitor Discovered To Combat Antibiotic Resistance 1/10/2014  More...
NovoCure Ltd. Release: Data Published In Pancreatology Demonstrates Activity Of NovoTTF™ Therapy In Preclinical Models Of Pancreatic Cancer, Alone And In Combination With Chemotherapy 1/7/2014  More...
Catalyst Pharmaceutical Partners, Inc. (CPRX) Reports Successful Completion Of Type B Breakthrough Therapy Meeting With FDA On Firdapse Tablets Development Program 1/6/2014  More...
New Research Published In Journal Of Biotechnology Highlights Utility Of InVitria’s Recombinant Human Leukemia Inhibitory Factor In Stem Cell Culture 1/6/2014  More...
Immune Response BioPharma To Develop Annual HIV Vaccine RemuneVax Based On Current HIV Strain 12/23/2013  More...
Galectin Therapeutics Release: Published Preclinical Study Demonstrates Therapeutic Effect Of Galectin Inhibitors In Fatty Liver Disease With Fibrosis 12/19/2013  More...
Alnylam Pharmaceuticals (ALNY) Presents New Pre-Clinical Data On Pharmacology Of Galnac-Sirna Conjugates 12/19/2013  More...
Biocryst Pharmaceuticals (BCRX) Advances Second Generation Oral Plasma Kallikrein Inhibitors For Hereditary Angioedema Into Preclinical Development 12/18/2013  More...
Preclinical Data Support Endocyte, Inc. (ECYT)'s Folate Receptor-Targeted Small Molecule Drug Conjugates For Treatment Of Triple Negative Breast Cancer 12/17/2013  More...
Galapagos NV (GLPG.BR) Selects Pre-Clinical Candidate For Cystic Fibrosis 12/16/2013  More...
Evotec AG (EVTG.F): Results Of Pre-Clinical Studies Lead To Reduction In Revenues, Nevertheless Profitable And More Than EURO 90 M Cash For 2013 Confirmed 12/13/2013  More...
Evotec AG (EVTG.F) Receives Pre-Clinical Milestone As Part Of Its Discovery Alliance With Boehringer Ingelheim Corporation 12/10/2013  More...
MacroGenics, Inc. (MGNX) Announces Presentation Of Pre-Clinical Data On DART® Molecule Targeting CD123-Positive Leukemic Stem Cells At 55th Annual Meeting Of The American Society of Hematology 12/10/2013  More...
Selecta Biosciences, Inc. Announces Successful Pre-Clinical Study Of SEL-201 As An Antigen-Specific Immune Tolerance Treatment For Patients Receiving Factor VIII Therapy 12/9/2013  More...
True North Therapeutics Presents Preclinical Results Showing Potential Of TNT009 To Treat Complement-Mediated Rare Diseases 12/9/2013  More...
Nimbus Discovery IRAK4 Inhibitor Demonstrates Synergistic Effects In Preclinical Studies With Three Kinase Inhibitors For The Treatment Of Lymphoid Malignancies 12/9/2013  More...
Synta Pharmaceuticals (SNTA) Announces Publications Demonstrating Ganetespib Activity In Triple-Negative Breast Cancer Models 11/22/2013  More...
Aratana Therapeutics Announces Positive Top-Line Results From AT-001 Dose-Ranging Field Study In Client-Owned Dogs With Osteoarthritis 11/21/2013  More...
Animal Study Published In Muscles, Ligaments And Tendons Journal Demonstrates Use Of Rotation Medical Collagen Scaffold To Induce Formation Of New Tendon-Like Tissue 11/20/2013  More...
Inovio Pharmaceuticals (INO)'s DNA Vaccine For The Deadly MERS Virus Induces Robust Immune Response In Preclinical Trial 11/20/2013  More...
Capstone Therapeutics (CAPS) Announces A Lipimetix Development, LLC Presentation At The American Heart Association Scientific Sessions: Pre-Clinical Data Demonstrating Significant Post Treatment Benefit Of AEM-28 On Established Atherosclerotic Lesions 11/19/2013  More...
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Publication Of Preclinical Proof-Of-Principle Of CPP-115 Efficacy in Suppressing Infantile Spasms In Epilepsia 11/18/2013  More...
Cempra Pharmaceuticals, Inc. Release: Preclinical Study Suggests That Solithromycin May Provide An Effective Antimicrobial Approach For Prevention And Treatment oOf Intrauterine Infections In Pregnancy 11/18/2013  More...
OXiGENE (OXGN) Announces Preclinical Data Presentation On Novel Anticancer Compounds, Benzosuberenes, Demonstrating Potent Anti-Proliferative Activity 11/18/2013  More...
Enzo Biochem (ENZ) Announces Study In Leading Scientific Journal Linking Idiopathic Pulmonary Fibrosis, A Deadly Human Disease With No Effective Treatment Options, To Presence Of A Monkey Virus 11/15/2013  More...
Aduro Biotech Presents Preclinical Data On Enhanced Anti-Tumor Activity With Small-Molecule Immunotherapy Program 11/14/2013  More...
iPierian Inc. Announces Oral Presentation Of Tau Antibody Preclinical Efficacy Study Which Showed Significant Reduction In Alzheimer’s Disease Progression 11/13/2013  More...
Tekmira Pharmaceuticals Corporation Announces New Preclinical Data From Anti-Viral Programs 11/13/2013  More...
Anavex Life Sciences Corp. (AVXL.OB) Announces Positive Data For ANAVEX 2-73 In Alzheimer's Disease 11/12/2013  More...
Antegrin Announces Publication In Nature Medicine Of Preclinical Data In Fibrosis Models 11/12/2013  More...
Neuroptis Biotech Announces The Preclinical Results For Its Dry Eye Product ML7 11/12/2013  More...
AM-Pharma Holding BV Presents Positive Data From recAP Preclinical Study at American Society of Nephrology Meeting 11/8/2013  More...
Regulus Therapeutics, Inc. Presents Positive Preclinical Data Demonstrating That microRNA-21 Plays an Important Role in Alport Syndrome 11/8/2013  More...
"New" Infectious Diseases: Clinical Tests on Innovative Themis Vaccine 11/7/2013  More...
HemoShear, LLC to Develop Human Cancer Models to Improve Industry Success Rates in New Anticancer Drug Development 11/7/2013  More...
Emergent BioSolutions (EBS) Presents Preclinical Data on ES414, Its Lead Bispecific ADAPTIR Therapeutic for Prostate Cancer 11/6/2013  More...
VG Life Sciences, Inc. (VGLS) Announces the Initiation of IND-Enabling Animal Safety Studies 11/4/2013  More...
Achillion Pharmaceuticals, Inc. (ACHN)'s Uridine-Analog Nucleotide Prodrug, ACH-3422, Shows Compelling Preclinical Profile 11/4/2013  More...
Safety of Pluristem Therapeutics (PSTI)'s PLX Cells Demonstrated in Pre-Clinical Pregnancy Model 11/4/2013  More...
Regulus Therapeutics, Inc. Release: Positive Preclinical Profile of RG-101, a GalNAc-conjugated anti-miR Targeting microRNA-122, Supports Clinical Development for the Treatment of HCV 11/4/2013  More...
AlphaMed Release: MAPCs Bring Lasting Improvements After Brain Injury, Pre-Clinical Study Finds 11/4/2013  More...
AIMM Therapeutics' Pre-Fusion RSV Antibodies Facilitate Improved Approach to Vaccine Development 11/4/2013  More...
SAGE Therapeutics’s Discovery of Novel Allosteric Therapeutic Approach for a Broad Range of CNS Disorders Published in Journal of Neuroscience 10/30/2013  More...
Aeolus Pharmaceuticals Inc. (AOLS.OB)' AEOl 10150 Significantly Improves Survival and Protects Lungs in Mice Exposed to Lethal Radiation 10/29/2013  More...
Neovasc Inc. (NVC) Announces Publication of Positive Tiara™ Preclinical Data in the Journal JACC: Cardiovascular Interventions 10/29/2013  More...
Ablynx (ABLYF) to Present Pre-clinical Proof-of-Concept Data on ALX-0761 at American College of Rheumatology 10/28/2013  More...
Karyopharm Therapeutics Announces Oral Presentations at the American College of Rheumatology on the Use of Selective Inhibitors of Nuclear Export (SINE) XPO1 Antagonists in Preclinical Models of Autoimmune Disease 10/23/2013  More...
ZIOPHARM Oncology, Inc. (ZIOP.OB) and Intrexon Corporation Announce Presentation of Data Highlighting Versatility of Novel Gene Expression and Control Technology 10/22/2013  More...
Stellar Biotechnologies, Inc. Immunotherapy Technology Demonstrates Protection Against Clostridium Difficile Infection in Preclinical Study 10/21/2013  More...
NanoViricides, Inc. (NNVC.PK) Says Early Results Indicate that FluCide® Was Extremely Safe in a Non-GLP Small Animal Tox Study 10/21/2013  More...
Celmatix, Inc. Study Shows Women May be Stopping IVF Treatment Prematurely 10/17/2013  More...
Preclinical Results Show Alliqua, Inc. (Formerly known as HepaLife Technologies Inc.) (ALQA)'s Investigational Lidocaine Transdermal Patch Compares Favorably to Lidoderm Patch 10/16/2013  More...
OXiGENE (OXGN) to Present Preclinical Data Demonstrating Antitumor Activity of ZYBRESTAT® in Pancreatic Neuroendocrine Tumor Model 10/16/2013  More...
Compugen Ltd. (CGEN) Presents Experimental Results Supporting Induction of Immune Tolerance by CGEN-15001 Drug Candidate 10/16/2013  More...
S-TARget Achieves Clinical Proof of Concept for Allergy Vaccine SG100 in Asthmatic Non-Human Primates 10/10/2013  More...
Medivir AB (MVIRb.F) Release: MIV-247 Has Been Selected as a Candidate Drug and Enters Development for the Treatment of Neuropathic Pain 10/10/2013  More...
Galectin Therapeutics' Preclinical Data Published in PLOS ONE Show Its Galectin Inhibitors Reverse Cirrhosis and Significantly Reduce Fibrosis and Portal Hypertension 10/10/2013  More...
Medivir AB (MVIRb.F): MIV-247 Has Been Selected as a Candidate Drug and Enters Development for the Treatment of Neuropathic Pain 10/10/2013  More...
Dicerna Pharmaceuticals Announces Publication of Data Demonstrating Tumor Growth Inhibition From Knockdown of Key Oncogene Using Dicer Substrate RNAi Compounds 10/9/2013  More...
Compugen Ltd. (CGEN) Drug Candidate Demonstrates High Effectiveness in Type I Diabetes Animal Model 10/9/2013  More...
Constellation Pharmaceuticals Announces New Preclinical Data on Novel BET Bromodomain Inhibitors Published in The Journal of Experimental Medicine 10/8/2013  More...
MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) Announces Preclinical Data on Type 1 Diabetes and Filing of Intellectual Property 10/4/2013  More...
Takeda Pharmaceutical Co. Ltd. (TKPYY) Highlights Data From Clinical Trial of Investigational Norovirus Vaccine Candidate 10/4/2013  More...
ENDECE Neural's NDC-1308 Potently Enhances Remyelination in Experimental Models of Multiple Sclerosis (MS) 10/4/2013  More...
Addex Therapeutics (ADXN.SW) ADX71441 Dose Dependently Reduced PMP22 Expression Comparable to Baclofen in a Pre-Clinical Transgenic Model of Charcot-Marie-Tooth 1A Disease 10/3/2013  More...
Pluristem Therapeutics (PSTI)''s PLX Cells Demonstrate Efficacy in Preclinical Study for Graft Versus Host Disease 10/1/2013  More...
Arno Therapeutics to Present Data Validating Target Biomarker at European Cancer Congress 2013 9/30/2013  More...
Zealand Pharma  (ZEAL.CO) Presents New Preclinical Data on its GLP-1-Gastrin Dual Agonist, Which Shows Potential as a Novel Approach for the Treatment and/or Prevention of Type 2 Diabetes 9/26/2013  More...
Tekmira Pharmaceuticals Corporation Presents New Anti-Viral Efficacy Data Against the Marburg Hemorrhagic Fever Virus 9/25/2013  More...
Bio-Matrix Scientific Group Inc. (BMSN.OB)'s Subsidiary, Regen BioPharma Announces dCellVax Breast Cancer Immunotherapeutic Product 9/25/2013  More...
Stemline Therapeutics, Inc. (STML) Announces Oral Presentation of SL-401, a Clinical-Stage Targeted Therapy, Demonstrating Notable Preclinical Activity in an Additional Indication, Chronic Myeloid Leukemia (CML), at the 15th International Conference on CML 9/25/2013  More...
Profectus BioSciences, Inc. Presents Data at Filovirus Medical Countermeasures Meeting Showing That a Single Dose of VSV-Vectored Vaccine Completely Protects Monkey Against Challenge With Ebola and Marburg Viruses 9/24/2013  More...
StemCells Inc. (STEM) Announces New Preclinical Data Showing HuCNS-SC® Cells Preserve Visual Function by Keeping Photoreceptors Normal and Healthy 9/18/2013  More...
SignaBlok Achieves Key in Vivo Proof of Concept for Treatment of Cancer and Sepsis 9/17/2013  More...
Compugen Ltd. (CGEN) Target for Cancer Immunotherapy Shown to Affect Multiple Immune Cell Types Involved in Tumor Progression 9/17/2013  More...
NanoViricides, Inc. (NNVC.PK) Reports It has Successfully Improved HIVCide Drug Candidate in Cell Culture Studies 9/16/2013  More...
Fedora Pharmaceuticals Inc. Demonstrates that FPI-1465 Increases Activity of Certain Antibiotics Against Drug-Resistant Bacteria 9/13/2013  More...
Visterra, Inc. Announces an Oral Presentation of VIS410 Data that Showed Neutralization of H5 and H7 Influenza Strains With Pandemic Potential 9/13/2013  More...
PRECOS Highlights Latest Advances in PDX Modelling for Oncology Drug Discovery to Increase Effectiveness of Drugs for Cancer Patients 9/13/2013  More...
Stem Cell Theranostics' "Clinical-Trial-in-a-Dish" Wows 9/13/2013  More...
Jenrin Discovery Announces Recent Advances in Understanding of the Endocannabinoid System Using JD-5037 9/12/2013  More...
Karo Bio AB Receives Funding From the National MS Society to Develop ERbeta Agonists for Treatment of Progressive Multiple Sclerosis 9/12/2013  More...
ICAAC Presentations Highlight Potential Protective Effects of Novavax, Inc. (NVAX)' RSV Vaccine Candidate 9/11/2013  More...
Alcobra (ADHD)'s Pre-Clinical Fragile X Study for MG01CI Shows Significant Positive Results 9/10/2013  More...
ENDECE Neural's NDC-1308 Induces Remyelination In Models Of Multiple Sclerosis 9/10/2013  More...
Immunovaccine Inc. Reports Positive Results From Two Anthrax Studies 9/9/2013  More...
Visterra, Inc. Presents Prophylactic and Therapeutic Efficacy Data of VIS410 Against Multiple Influenza Strains With Pandemic Potential 9/9/2013  More...
Advaxis, Inc. Lead Product Candidate ADXS-HPV in Combination With PD-1 Antibody Significantly Improves Immune and Therapeutic Efficacy in Preclinical Study 9/5/2013  More...
Publication Demonstrates Superior Activity of ISA Pharmaceuticals' SLP® Vaccines Compared to Whole Protein Vaccines 9/4/2013  More...
XBiotech Announces It is Developing Therapy for MRSA 9/4/2013  More...
Chronic Treatment With Addex Therapeutics (ADXN.SW) Dipraglurant Rescues Impairment of Long-Term Synaptic Plasticity in a Validated Preclinical Model of Primary Generalized Torsion Dystonia 1 9/4/2013  More...
Novavax, Inc. (NVAX) to Present RSV Vaccine Clinical and Preclinical Results at ICAAC 9/3/2013  More...
PsychoGenics Inc. Obtains an Exclusive License to the APP/PS1 Transgenic Mouse Model of Alzheimer’s Disease 8/21/2013  More...
Coffee and Tea May Contribute to a Healthy Liver, Duke-NUS Graduate Medical School Study 8/16/2013  More...
Argos Therapeutics, Inc. Identifies Topical Formulation for Prolonged Graft Survival in Corneal Transplants 8/15/2013  More...
Aileron Therapeutics Publishes Data Demonstrating ATSP-7041 as First-in-class p53 Pathway Re-activator for the Treatment of Solid and Hematologic Cancers 8/15/2013  More...
Peregrine Pharmaceuticals, Inc. (PPHM) Release: Bavituximab's Mechanism of Action Highlighted at Immunomodulatory Therapeutic Antibodies for Cancer Conference 8/15/2013  More...
Amorfix Life Sciences Ltd. Reports Update on Lead Ovarian Cancer Program 8/14/2013  More...
Amarantus BioSciences, Inc. Announces Positive Orphan Data for MANF in Retinitis Pigmentosa 8/12/2013  More...
Karyopharm Therapeutics Announces Preclinical Data for Selinexor (KPT-330) in Acute Myeloblastic Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL) Models at FASEB Science Research Conferences 8/8/2013  More...
BioLineRx Ltd. Announces Publication of Positive Pre-Clinical Results for BL-8040 in Treatment of Thrombocytopenia 8/5/2013  More...
AllaChem Announces the Completion of Pre-Clinical Studies With ONC1-13B, a New Effective Anti-Androgen for the Treatment of Prostate and Breast Cancers 8/5/2013  More...
SIGA Technologies, Inc. (SIGA) Selects Lead Candidate for Dengue Antiviral Program 8/2/2013  More...
Celladon Corporation Announces Pre-clinical Study Demonstrating Inhalable MYDICAR Reverses Pulmonary Arterial Hypertension (PAH) 7/30/2013  More...
Novavax, Inc. (NVAX) Publishes Positive Preclinical Efficacy Data Against Influenza A(H7N9) 7/29/2013  More...
Provectus Pharmaceuticals Inc. Release: PV-10's Systemic Tumor-Specific Immune Response is Subject of Research Article Published in PLOS ONE 7/25/2013  More...
Kala Pharmaceuticals Presents Data Demonstrating Topical Delivery to Posterior Segment of the Eye 7/23/2013  More...
Astex Pharmaceuticals (ASTX) Announces First Data Showing Early Combination Treatment of HSP90 Inhibitor AT13387 With Targeted Agents Delays Emergence of Resistance in Preclinical Models 7/22/2013  More...
Bio-Path Holdings, Inc. (BPTH) Initiates Development of Liposomal Grb-2 for Triple Negative and Inflammatory Breast Cancers 7/22/2013  More...
Rib-X Pharmaceuticals, Inc. Presents Data Demonstrating Potent In Vitro Activity of Delafloxacin Against Drug-Resistant Gonorrhea 7/16/2013  More...
Inovio Pharmaceuticals (INO)' Universal H7N9 DNA Vaccine Protects 100% of Vaccinated Animals in Challenge Study 7/8/2013  More...
VBL Therapeutics Discloses Data About VB-201 Novel Mechanism and Pre-Clinical Efficacy in Atherosclerosis 7/8/2013  More...
Cellectis Announces Groundbreaking in Vivo Proof of Concept Testing of Their Flagship UCART19 Product for Curative Therapy of Leukemia 7/8/2013  More...
Innovus Pharma Initiates Primate Safety Studies of Its Products That Affect Premature Ejaculation and Penile Sensation 7/3/2013  More...
Biodel Inc. (BIOD) to Present New Preclinical Glucagon Data During Corporate Overview at JMP Securities Healthcare Conference 7/3/2013  More...
Alnylam Pharmaceuticals (ALNY) Presents New Pre-clinical Data on ALN-AT3, an RNAi Therapeutic Targeting Antithrombin (AT) for the Treatment of Hemophilia and Rare Bleeding Disorders 7/2/2013  More...
Aeolus Pharmaceuticals Inc. (AOLS.OB)' AEOL 10150 Significantly Improves Survival From Nitrogen Mustard Exposure to Skin in Animals 7/2/2013  More...
Preclinical Data From Biogen Idec, Inc. (Massachusetts) (BIIB)-Amunix, Inc. Partnership Presented at ISTH Congress 7/2/2013  More...
AtheroNova Inc. (AHRO.OB) Announces Publication of Positive Pre-Clinical Results with AHRO-001 in the FASEB Journal 6/27/2013  More...
Vaxart, Inc. Creates Effective Oral H7N9 Avian Influenza Vaccine in 20 Days 6/26/2013  More...
Aeolus Pharmaceuticals Inc. (AOLS.OB)'s AEOL 10150 Significantly Improves Survival in Animals Exposed to Mustard Gas 6/26/2013  More...
Amicus Therapeutics, Inc. (FOLD) Announces Chaperone-Advanced Replacement Therapy in Development for Mucopolysaccharidosis Type I (MPS I) 6/25/2013  More...
SciFluor Life Sciences, LLC Presents New Preclinical Data Highlighting Lead Program as a More Potent and Selective Treatment for Partial-Onset Seizure 6/25/2013  More...
Ligand Pharmaceuticals Inc. (LGND) Announces Positive Preclinical Data for Glucagon Program in Model of Type 1 Diabetes 6/24/2013  More...
Nimbus Discovery Presents Compelling Preclinical Proof of Concept Data on Novel ACC Allosteric Inhibitor ND-630 6/24/2013  More...
Lexicon Pharmaceuticals, Inc. (LXRX) Presents Preclinical Data on LX2761, a New Clinical Candidate for Diabetes Designed to Reduce Glucose Absorption From Gastrointestinal Tract 6/24/2013  More...
Idenix Pharmaceuticals, Inc. (IDIX) Falls After FDA Delays Hepatitis C Drug Trial 6/21/2013  More...
Pluristem Therapeutics (PSTI)'s Preclinical Results for Its PLX-RAD Cells Published in the Journal PLOS ONE 6/20/2013  More...
TG Therapeutics, Inc. (MHA) Announces Presentation of Pre-Clinical Data on the Combination of TG-1101 and TGR-1202 at the International Conference on Malignant Lymphoma, Lugano, Switzerland 6/20/2013  More...
Alnylam Pharmaceuticals (ALNY) Scientists Present Pre-clinical Data with ALN-CC5, an RNAi Therapeutic Targeting Complement Component C5 for the Treatment of Complement-Mediated Diseases 6/20/2013  More...
Acetylon Pharmaceuticals Announces Preclinical Data of ACY-1215 for the Treatment of Lymphoma Highlighted at 12th International Conference on Malignant Lymphoma (ICML) 6/20/2013  More...
Zalicus Inc. (ZLCS) Publishes Data on Selective Estrogen Receptor Modulators for the Treatment of Infectious Disease 6/20/2013  More...
PRANA Biotechnology (PRAN) Release: PBT434 Drug Candidate Shows Potential as "Next-Generation" Disease-Modifying Treatment in Parkinson's Disease 6/20/2013  More...
Amarantus BioSciences, Inc. Reports Positive Results on MANF Neuroprotective Properties Demonstrated in Preclinical Study in China 6/19/2013  More...
TG Therapeutics, Inc. (MHA) Announces Presentation of Pre-Clinical Data on the Combination of TG-1101 and TGR-1202 at the International Conference on Malignant Lymphoma, Lugano, Switzerland 6/19/2013  More...
Sanford-Burnham Medical Research Institute Researchers Develop Novel Drug That Reverses Loss of Brain Connections in Models of Alzheimer's 6/18/2013  More...
Isotechnika Pharma Inc. (ISA.TO) Receives Additional Funding From the Government of Canada for the Preclinical Development of NICAM 440-02 as an Anti-Hepatitis C Agent 6/18/2013  More...
TG Therapeutics, Inc. (MHA) Announces Clinical and Pre-Clinical Poster Presentations for TG-1101 and TGR-1202 at the European Hematology Association Meeting in Stockholm, Sweden 6/17/2013  More...
Inovio Pharmaceuticals (INO)'s Universal H7N9 DNA Vaccine Generates First Protective Antibody Responses Against Virulent H7N9 Virus in 100% of Vaccinated Animals 6/14/2013  More...
Cocoa May Help Fight Diabetes, Inflammation, Penn State University Study 6/13/2013  More...
Brain Circuits Link OCD Behavior and Obesity, University of Iowa Study 6/11/2013  More...
NanoViricides, Inc. (NNVC.PK) Submits DengueCide™ Orphan Drug Designation Application to the FDA for Dengue and Dengue Hemorrhagic Fever 6/10/2013  More...
AngioLight Completes Animal Study at Fu Wai Hospital; Begins Preparing for China Food and Drug Administration (CFDA) Regulatory Testing 6/6/2013  More...
Champions Oncology, Inc. (CSBR) Study Results Highlighted in Presentation at American Society of Clinical Oncology 6/5/2013  More...
Amorfix Life Sciences Ltd. Provides Update on Ovarian Cancer Preclinical Studies 6/5/2013  More...
Achillion Pharmaceuticals, Inc. (ACHN) Nominates ACH-3422 as Nucleotide for the Treatment of Chronic HCV 5/30/2013  More...
Karyopharm Therapeutics to Present New Data on Selective Inhibitor of Nuclear Export (SINE), KPT-330, at 2013 European Hematology Association Congress 5/29/2013  More...
Novartis AG (NVS) Ramps Up Alzheimer's Drug Pursuit as Rivals Fail 5/24/2013  More...
Arsanis, Inc. Nominates Preclinical Candidate for Staphylococcus aureus Program 5/23/2013  More...
Pfizer Inc. (PFE) Takes Its Shot at a Vaccine for Evasive MRSA Superbug 5/23/2013  More...
H. Lundbeck A/S (LUN.CO) Release: Vortioxetine, a New Multimodal Agent in Development for the Treatment of Major Depression, Shows Effects on Cognitive Function in Several Preclinical Animal Models 5/22/2013  More...





 

//-->